HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1790501Generated: November 2, 2026
1-[1-(4-Fluorophenethyl)piperidin-4-yl]-6-[(isobutylcarbamoyl)methyl]indoline → 1-[1-(4-Fluorophenethyl)piperidin-4-yl]-6-(ethylcarbamoylmethyl)indole
https://huagongshe.com/reaction/1790501
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-[1-(4-Fluorophenethyl)piperidin-4-yl]-6-[(isobutylcarbamoyl)methyl]indoline | HCID 22037973 | — |
| Catalyst | HCID 178418406 | HCID 178418406 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | 1-[1-(4-Fluorophenethyl)piperidin-4-yl]-6-(ethylcarbamoylmethyl)indole | HCID 22038379 | 76.7% |
Reaction Steps
A suspension of 1-[1-(4-fluorophenethyl)piperidin-4-yl]-6-[(isobutylcarbamoyl)methyl]indoline (0.07 g) obtained in Example 152 and active manganese dioxide (0.07 g) in chloroform (30 ml) was vigorously stirred at 50° C. overnight. Then the reaction mixtures were filtered through celite and the residue was washed with chloroform. After concentrating the filtrate under reduced pressure, the residue was recrystallized from chloroform/hexane to give the title compound (0.05 g) as a white powder (yield: 70.0%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07071201B2 |
|---|
| Source dataset | uspto-grants-2006_07 |
|---|
| ORD ID | ord-7ba06a0745eb45d59643d5c89d39e192 |
|---|
| Source note | uspto-grants-2006_07 |
|---|